Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Goliath Drilling Confirms 100% Of The First 8 Holes Of 2024 Hit Significant Mineralization, 75% Of The Holes Contain Abundant Visible Gold Up To 1.3mm In Size, Surebet Discovery, Golden Triangle B.C.
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
-
Ingredion Incorporated Reports Strong Second Quarter Results and Raises Full-Year Outlook
-
Calibre Announces Receipt of the Federal Environmental Assessment Approval for the Berry Pit at the Valentine Gold Mine, Newfoundland & Labrador, Canada
-
Calibre Announces Receipt of the Federal Environmental Assessment Approval for the Berry Pit at the Valentine Gold Mine, Newfoundland & Labrador, Canada
-
Hesai Group to Report Second Quarter 2024 Financial Results on Monday, August 19, 2024
-
REMSleep Holdings Inc. Issues Shareholder Letter
-
A Win-Win Strategic Agreement Announced between Ennoconn as Exclusive Hardware Provider for NCR Voyix
-
BLUESTONE LANE NOW SERVING WORLD’S MOST SUSTAINABLE COFFEE NATIONALLY
-
Net Asset Value(s)
-
Notice on Concluded Lease Agreement
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
NeoVolta Expands Market Reach with New Approvals from EnFin Solar Loans and Sungage Financial
-
Clean Energy Technologies, Inc. CEO joins California-Latvia economic development and cross-sector cooperation delegation; addresses business forum
-
Grindrod Shipping Holdings Ltd. Announces Voluntary Delisting from Nasdaq Global Select Market
-
DSV, 1126 - SHARE BUYBACK IN DSV A/S
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc
-
Closure of Offer for Subscription
-
TRREB: Buyer Activity Increases Slightly in July
-
UN Global Compact Drives Sustainable Business Forward at Asia & Oceania Event
-
Ambarella Announces Second Quarter Fiscal Year 2025 Earnings Conference Call to be Held August 27, 2024
-
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
-
UN Global Compact Drives Sustainable Business Forward at Asia & Oceania Event
-
Form 8.5 (EPT/RI) - Alpha Financial Markets Consulting Plc
-
Form 8.5 (EPT/RI) - Renalytix Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BELLWAY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
BNP Paribas Primary New Issues: STAB Notice - NO STAB - OCADO GROUP PLC
-
Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Form 8.3 - International Distribution Services Plc
-
Form 8.5 (EPT/RI) - Global Ports Holding Plc
-
leon-nanodrugs secures funds in a series D financing to broaden portfolio in first single-use high throughput production systems for nanoencapsulation
-
Release Therapeutics Secures CHF 3.3 Million in Seed Funding
-
EZVIZ wins the Sustainability Award’s Initiative of the Year for EZVIZ Green, which drives eco-conscious innovations while fostering global forests
-
Benoit Geurts Joins Gordon Brothers as Managing Director, Intellectual Property, EMEA
-
Futu to Report Second Quarter 2024 Financial Results on August 20, 2024
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
OKX Wallet Announces Agni Finance Integration, Now Supports Nearly 500 DEXs
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Jartoo Launches Revolutionary Baby Monitor with Advanced Cry Sensor and 2K Video Quality
-
The results of the voluntary takeover offer made by AS Infortar in respect of the shares of AS Tallink Grupp
-
Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04, for the Treatment of Patients with Moderate to Severe Osteoarthritis
-
Innofactor Plc: Notification of major holdings in accordance with Chapter 9, Section 10 of the Finnish Securities Markets Act
-
Share buybacks in Spar Nord Bank – transactions in week 31
-
Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
-
VALNEVA - Declaration of shares and voting rights: July 31, 2024
